Principales centros de investigación en neurodegeneración
Explore the leading research centers dedicated to advancing the understanding and treatment of neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. These cutting-edge institutes conduct basic and clinical research, offer specialized diagnostics, and develop innovative clinical trials. Discover the institutions that are transforming the future of brain health and medicine. Multidisciplinary collaboration is key to understanding the mechanisms of these complex pathologies.
318100% verified
1
Ace Alzheimer Center Barcelona (Barcelona, Barcelona)
318 Global Votes
Participates in 17 clinical trials for Alzheimer's disease
(+4)
Ace Alzheimer Center Barcelona is a leading institution in Alzheimer's disease research, actively participating in over 170 clinical trials and managing the largest Alzheimer's genetic cohort. Its commitment to scientific excellence is demonstrated through projects like GR@ACE, which drives the discovery of new genes and future treatments, and by organizing global research summits.
Barcelonaβeta Brain Research Center (Barcelona, Barcelona)
0 Global Votes
Focuses on Alzheimer's prevention
(+4)
The Barcelonaßeta Brain Research Center (BBRC) is dedicated to the prevention of Alzheimer's disease and the study of cognitive aging. Its focus on neurodegeneration research and cognitive functions positions it as a key player in this field. The center performs fundamental work in understanding and addressing neurodegenerative diseases.
Centro de Investigación de Enfermedades Neurológicas (CIEN)
0 Global Votes
Supports, promotes, and coordinates neurodegenerative disease research
(+3)
CIEN is a leading center in neurodegenerative disease research, notable for its focus on precision medicine for Alzheimer's diagnosis and treatment. Its involvement in innovative projects like FluiDx-AD, which develops minimally invasive diagnostic tests, underscores its commitment to scientific advancement in this critical field.
Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED)
0 Global Votes
Fosters scientific and technical research of excellence
(+4)
CIBERNED is a leading institution in neurodegenerative disease research, with a clear goal of fostering scientific and technical excellence. Its annual Scientific Forum, an international conference since 2013, facilitates knowledge exchange and collaboration among researchers worldwide in this crucial field.
Instituto de Investigación Sanitaria Valdecilla (IDIVAL)
0 Global Votes
Discovers genetic variant protecting against Alzheimer's and dementia
(+4)
IDIVAL hosts a Neurodegeneration and Neuroinflammation group dedicated to advancing knowledge in neurodegenerative disorders through a multidisciplinary and translational approach. Its studies include research into diseases like Parkinson's and the evaluation of associations between depressive symptoms and amyloid pathology, significantly contributing to progress in this field. Furthermore, the institute provides comprehensive support for high-complexity clinical trials, facilitating cutting-edge neurodegeneration research.
Thousands of verified votes to discover the best. Your vote here counts
6
Mount Sinai Alzheimer's Disease Research Center
0 Global Votes
Comprehensive research facility and clinical program
(+4)
This center is a leader in Alzheimer's disease research, with a history since 1984 as an NIA-funded Center of Excellence. Its comprehensive approach spans from cutting-edge research to clinical and support programs for patients and caregivers, including advancements in blood biomarkers and health equity.
Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases
0 Global Votes
National Center of Excellence for Dementia Care and Research
(+4)
This institute is the only National Institute on Aging (NIA)-designated center in Texas for dementia research and care, highlighting its leadership in the field. It provides comprehensive care and advances treatment through clinical trials and a brain bank, significantly contributing to the understanding and fight against neurodegenerative diseases.
Center for Neurodegenerative Disease Research (CNDR)
0 Global Votes
Promotes and conducts multidisciplinary research
(+4)
CNDR is a leading center in neurodegenerative disease research, with 25 years of experience advancing knowledge about their causes and mechanisms. Its multidisciplinary approach spans from basic research to clinical studies and new drug development, significantly contributing to the search for treatments.
The Iowa Center for Neurodegeneration stands out for its integrated approach to basic science and clinical research, enabling effective translation of discoveries into treatments. Its mission to improve care for underserved rural populations in Iowa and beyond underscores a significant societal commitment in the fight against neurodegenerative diseases.
ASU-Banner Neurodegenerative Disease Research Center
0 Global Votes
Advances discovery of disease mechanisms, risk factors, biomarkers, and drugs
(+2)
This center is crucial for neurodegeneration research by driving the discovery of disease mechanisms, risk factors, and biomarkers. Its focus on developing new drugs and early detection techniques, such as blood biomarkers, positions it as a key player in the fight against these conditions.
The NIA leads federal research on Alzheimer's disease and related dementias, being instrumental in the development of biomarkers and diagnostic criteria. Its extensive research program spans from genetic studies to clinical trials, including key initiatives like the NIA-AD FBS and support for exploratory centers for underrepresented populations.
EU Joint Programme – Neurodegenerative Disease Research (JPND)
0 Global Votes
Largest global research initiative
(+4)
JPND is the largest global research initiative dedicated to neurodegenerative diseases, coordinating efforts across 30 countries to find cures and improve diagnosis. Its focus on coordinated investment and transnational calls for cutting-edge research positions it as a key player in this field.
This ranking highlights leading research centers dedicated to understanding and treating neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS, based on their impact and contributions to research.
Centers are selected based on their involvement in global research initiatives, multidisciplinary approach, advancements in understanding disease mechanisms, and development of new therapeutic strategies, as well as their recognition by relevant institutions.
The results of this ranking reflect the visibility and influence of centers in the field of neurodegeneration research, serving as a guide to identify institutions with significant contributions and active research programs.
Currently, the ranking is based on publicly available information and the context of recognized research initiatives. Centers interested in being considered can ensure their work and achievements are widely disseminated within the scientific community.
How we built this ranking and what to consider when choosing
Our methodology for ranking neurodegeneration research centers focuses on identifying institutions that demonstrate significant leadership and impactful contributions to the field. We assess participation in global research networks, the breadth of their scientific approach, and their ability to advance the understanding and treatment of these complex diseases.
We consider participation in major global research initiatives, such as the Neurodegenerative Disease Research (JPND), which pools international efforts to tackle neurodegenerative diseases.
We evaluate the centers' ability to promote and conduct multidisciplinary clinical and basic research, integrating diverse areas of knowledge for a holistic understanding of diseases.
The existence of research programs focused on specific diseases such as Alzheimer's, Parkinson's, and ALS is valued, as well as the identification of underlying mechanisms and the development of new therapies.
Collaboration with other prestigious institutions and designation by national bodies, such as National Institute on Aging (NIA)-designated centers, are key indicators of their relevance and quality.
Centers must demonstrate active participation in large-scale research initiatives and international collaborations aimed at tackling neurodegenerative diseases.
Priority is given to centers with a multidisciplinary approach, integrating clinical, basic, and translational research for a comprehensive understanding of diseases.
The centers' ability to make significant discoveries in identifying disease mechanisms, biomarkers, and developing new therapeutic strategies is fundamental.
Centers that offer diagnosis, medical research, and support group programs are considered, demonstrating a comprehensive commitment to patients and the community.
